CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 1,068.2	$ 681.8
Short-term investments	100.0	50.0
Accounts receivable, net	416.9	335.3
Inventories	710.1	692.3
Assets held for sale	4.4
Other current assets	172.2	165.6
Total current assets	2,471.8	1,925.0
Property, plant and equipment, net	406.1	395.5
Goodwill	339.5	320.4
Intangible assets, net	211.8	229.1
Operating lease assets	59.9	67.4
Deferred tax assets	90.1	72.0
Other long-term assets	70.8	39.6
Total assets	3,650.0	3,049.0
Current liabilities:
Current portion of long-term debt	112.4	2.2
Accounts payable	147.4	134.6
Customer advances	197.5	189.2
Other current liabilities	481.2	465.9
Total current liabilities	938.5	791.9
Long-term debt	1,221.8	842.3
Long-term deferred revenue	50.2	50.9
Deferred tax liabilities	46.0	43.1
Operating lease liabilities	41.8	47.0
Accrued pension	104.7	123.4
Other long-term liabilities	162.2	176.1
Redeemable noncontrolling interest	0.2
Shareholders' equity:
Preferred stock, $0.01 par value 5,000,000 shares authorized, none issued or outstanding at December 31, 2021 and 2020	0.0	0.0
Common stock, $0.01 par value 260,000,000 shares authorized, 174,905,035 and 174,045,610 shares issued and 150,753,687 and 151,987,081 outstanding at December 31, 2021 and 2020, respectively	1.7	1.7
Treasury stock at cost, 24,151,348 and 22,058,529 shares at December 31, 2021 and 2020, respectively	(820.3)	(667.0)
Additional paid-in capital	237.8	216.3
Retained earnings	1,659.5	1,406.5
Accumulated other comprehensive (loss) income	(8.2)	3.7
Total shareholders' equity attributable to Bruker Corporation	1,070.5	961.2
Noncontrolling interests in consolidated subsidiaries	14.1	13.1
Total shareholders' equity	1,084.6	974.3
Total liabilities, redeemable noncontrolling interest and shareholders' equity	$ 3,650.0	$ 3,049.0